The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

Podrobná bibliografie
Hlavní autoři: Foroni, L, Mitchell, W, Rai, L, Richards, S, Fielding, A, Goldstone, A
Médium: Conference item
Vydáno: 2005

Podobné jednotky